Revium Rx (RVRC) Total Liabilities (2024 - 2025)
Revium Rx (RVRC) reported Total Liabilities of $1.4 million for Q4 2025, up 145.66% on a YoY basis from $576000.0 in Q4 2024, and up 145.66% sequentially from $576000.0 in Q4 2024.
Revium Rx (RVRC) Total Liabilities (2024 - 2025) Analysis & Trends
Revium Rx (RVRC) has 2 years of Total Liabilities data on file, last reported at $1.4 million in Q4 2025.
- For the quarter ending Q4 2025, Total Liabilities rose 145.66% year-over-year to $1.4 million; the trailing twelve-month figure through Dec 2025 stood at $1.4 million (up 145.66% YoY), and the FY2025 full-year result was $1.4 million, up 145.66% from the prior year.
- Total Liabilities grew to $1.4 million in Q4 2025, from $576000.0 in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $1.4 million in Q4 2025 to a low of $576000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 32.25 Bn | 24.94 Bn | 662.02 Mn | 1.83 Bn |
| 2 | BrightSpring Health Services | 14.59 Bn | 13.69 Bn | 482.22 Mn | 4.22 Bn |
| 3 | Healthequity | 8.34 Bn | 8.08 Bn | 256.31 Mn | 1.26 Bn |
| 4 | Hinge Health | 5.99 Bn | 5.67 Bn | 154.23 Mn | 417.21 Mn |
| 5 | 10x Genomics | 5.88 Bn | 5.34 Bn | 106.18 Mn | 201.44 Mn |
| 6 | MiniMed | 4.50 Bn | 4.20 Bn | 480.00 Mn | 1.02 Bn |
| 7 | Waystar Holding | 4.47 Bn | 4.41 Bn | 216.84 Mn | 1.90 Bn |
| 8 | Doximity | 3.97 Bn | 3.22 Bn | 125.97 Mn | 172.85 Mn |
| 9 | Privia Health | 3.13 Bn | 2.71 Bn | - | 611.99 Mn |
| 10 | Revium Rx | 101.42 Mn | 98.71 Mn | - | 1.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.42 Mn |
| Dec 31, 2024 | 576,000.00 |